Catalyst
Pit
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
☰
IMVT
Immunovant, Inc.
NASDAQ · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Last close
$33.78
· 2026-09-30
ABOUT
Exchange
NASDAQ
Sector
Healthcare
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Market cap
$6.98B
Country
USA
RECENT INSIDER TRADES
2026-10-09
· Van Tuyl Christopher
(Chief Legal Officer)
· SELL
2026-10-09
· Stout Jay S
(Chief Technology Officer)
· SELL
2026-10-09
· Gloria Melanie
(Chief Operating Officer)
· SELL
2026-10-05
· Venker Eric
(Chief Executive Officer)
· SELL
INSTITUTIONAL OWNERSHIP
Institutional holders
246
Shares held
125,482,742
Value
$4.46B
Percent of shares outstanding
60.75%
As of quarter end
2026-06-30
RECENT NEWS
Immunovant CTO Jay Stout sells $122,116 in shares
Immunovant chief legal officer Van Tuyl sells $42,543 in stock
Immunovant COO Melanie Gloria sells shares worth $71,846
Immunovant CEO Eric Venker sells $119,589 in shares
Immunovant Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into Immunovant (IMVT)
Catalyst
Pit
Features
Coming soon
Pricing
Coming soon
Privacy
Terms
Disclaimer
Affiliate Terms
Contact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS